Bristol-Myers Squibb said its advertising and promotional spend increased by 23% in the third quarter, in part due to increased DTC advertising of Plavix and Abilify.
From the December 01, 2007 Issue of MM+M - Medical Marketing and Media
BMS says spend increased by 23% in Q3
Bristol-Myers Squibb said its advertising and promotional spend increased by 23% in the third quarter, in part due to increased DTC advertising of Plavix and Abilify.
